TAYLOR SZUCS: Open Payments
NPI 1922698877 · SHELBY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,302 in 400 payments from 23 companies in 2025. Trend: 2023 $5,870 · 2024 $5,759 · 2025 $6,302
Food & beverage: $6,211Education: $91
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 58 | $933 |
| ABBVIE INC. | 94 | $820 |
| Teva Pharmaceuticals USA, Inc. | 21 | $535 |
| Vanda Pharmaceuticals Inc. | 18 | $404 |
| Janssen Pharmaceuticals, Inc | 22 | $393 |
| Alkermes, Inc. | 20 | $378 |
| Otsuka America Pharmaceutical, Inc. | 31 | $362 |
| Axsome Therapeutics, Inc. | 18 | $348 |
| E.R. Squibb & Sons, L.L.C. | 15 | $320 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $313 |
Products named: INGREZZA, VRAYLAR, REXULTI, FANAPT, AUSTEDO XR, COBENFY, Auvelity, ARISTADA.
Industry payments across NC — which companies pay providers there.
